Nellix® Registry Study: EVAS-Global

NCT ID: NCT02018744

Last Updated: 2022-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-10-31

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This registry has been designed as a multicenter, single arm, open label, post-market registry study with consecutive, eligible patient enrollment at each site. All subjects undergoing the Endovascular Aneurysm Sealing System (EVAS) with the Nellix®-System. Subjects will be followed up to discharge discharge, and as per institutional standard of care thereafter through to 5 years (total follow-up commitment). This registry of the Nellix System, which has received the market authorization of the European Union (Conformité Européenne, CE-certification) in a "real world" patient population treated in a multicenter setting will provide an assessment of the generalizability of the approach and System.

Up to 300 patients diagnosed with abdominal aortic aneurysm (AAA) who are considered candidates for Endovascular Repair, in up to 30 international centers will be enrolled in the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Baseline: medical history, physical exams, CT image, bloodwork,
2. Procedure: implantation information
3. Discharge: Physical exam, bloodwork and adverse events, if any
4. Follow-up according to institutional standard through to 5 years including Physical exam, CT image or standard of care imaging eg Doppler Ultrasound, bloodwork and adverse events, if any

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Safety and Performance of the Nellix Endovascular Sealing System

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female at least 18 years old
2. Subject has signed informed consent for data release
3. Subjects with AAA and eligible for endovascular repair

Exclusion Criteria

1. Currently participating in another study where primary endpoint has not been reached yet
2. Known allergy to any of the device components
3. Pregnant (females of childbearing potential only)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Endologix

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Prof Andrew Holden

Role: PRINCIPAL_INVESTIGATOR

Auckland City Hospital

Dr. Michel Reijnen, MD

Role: PRINCIPAL_INVESTIGATOR

Rijnstate Hospital, Arnhem NL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum Augsburg Klinik für Gefäßchirurgie

Augsburg, , Germany

Site Status

Universitätsklinikum Düsseldorf Klinik für Gefäß- und Endovaskularchirurgie

Düsseldorf, , Germany

Site Status

Alfried Krupp Krankenhaus Ruttenscheid, Vascular Centre

Essen, , Germany

Site Status

Universitätsklinikum Heidelberg Klinik für Gefäßchirurgie Im Neuenheimer Feld

Heidelberg, , Germany

Site Status

Klinikum Sud Nuernberg, Dept of Vascular Surgery

Nuremberg, , Germany

Site Status

Klinikum Stuttgart Katharinenen Hospital

Stuttgart, , Germany

Site Status

Pauls Stadins Clinical University Hospital Riga

Riga, , Latvia

Site Status

Hopital Kirchberg, Dept of Cardio-Vascular

Luxembourg-Kirchberg, , Luxembourg

Site Status

Academisch Medisch Centrum Amsterdam, Department of Surgery

Amsterdam, , Netherlands

Site Status

Rijnstate Ziekenhuis, Vasculaire Centrum

Arnhem, , Netherlands

Site Status

St Antonius Ziekenhuis, Dept of Vascular Surgery

Nieuwegein, , Netherlands

Site Status

Erasmus Medical Centre, Dept of Vascular Surgery

Rotterdam, , Netherlands

Site Status

St Elisabeth Ziekenhuis, Dept of Vascular Surgery

Tilburg, , Netherlands

Site Status

Auckland City Hospital Interventional Radiology

Auckland, , New Zealand

Site Status

Hospital Hamar

Hamar, , Norway

Site Status

Orebro University Hospital, Department of General Surgery

Örebro, , Sweden

Site Status

Karolinska University Hospital

Stockholm, , Sweden

Site Status

Addenbrooke's Hospital, Dept of Vascular Surgery

Cambridge, , United Kingdom

Site Status

St. George's Vascular Institute

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Latvia Luxembourg Netherlands New Zealand Norway Sweden United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP0010-Ver. 1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Study of Aneurysm Exclusion
NCT00549380 UNKNOWN PHASE1
ANEUFIX for Endoleak Type II Repair
NCT03918460 RECRUITING NA
Global Fenestrated Anaconda Clinical STudy
NCT03180996 ACTIVE_NOT_RECRUITING
AneuFix - Prophylactic Sac Filling
NCT04307992 RECRUITING NA